Full-Time

Communications Program Manager

Deadline 1/2/27
Waters Corporation

Waters Corporation

10,001+ employees

Analytical instruments, software, and services provider

No salary listed

Franklin, MA, USA + 2 more

More locations: New Castle, DE, USA | Trafford, UK

Hybrid

Hybrid role requiring in-office Tuesday–Thursday.

Category
Business & Strategy (1)
Required Skills
Communications
Requirements
  • Life sciences/scientific background
  • Bachelor's degree in Communications, Public Relations, or related field
  • 7+ years of public relations experience
  • Excellent written, media relations, and digital communications skills
  • Ability to translate technical scientific content into engaging and memorable campaigns for external audiences
  • Driven to understand, simplify, and effectively communicate complex information
  • Demonstrated success achieving cross-functional influence and alignment on communications strategies and execution plans
  • Comfortable presenting to and advising company leadership and stakeholders; Prepares executive-ready communications, recommendations, and reports
  • Ensures consistency across communications and channels; Demonstrates exceptional organizational skills and strong attention to detail
  • Supports development and execution of audience-specific paid strategies; Shapes optimal content approaches and targeting based on audience behavior and business objectives
  • Leads by example, mentoring team members to enhance performance and processes
  • Appetite for continuous learning and advancement, including surfacing and proposing new ideas to achieve goals. Ability to challenge status quo
  • Distills high-level directives into actionable, focused, and measurable plans
Responsibilities
  • Serve as Global Communications lead for company announcement coordination, ensuring product launch communications excellence and consistency
  • Take full ownership over the end-to-end trade media program, with a strong emphasis on media strategy, messaging, and reporter relationships
  • Coordinate product launches across the company. Advise product promotion strategy. Oversee product press release development, messaging, and distribution
  • Translate technical, scientific topics and product specifications into compelling, engaging and relevant messaging for target audiences
  • Cultivate and expand relationships with priority publications
  • Fulfills role as a go-to trade media relations resource across the company. Provide consultations and trainings for leadership, internal subject matter experts, employees and customers. Prepare spokespeople for trade media interviews and engagements
  • Lead the design and development of trade media collateral, including media materials and messaging, Q&A documents, bylined articles and thought leadership commentary
  • Manage end-to-end trade award program, from opportunity evaluation and identification, through content development and submission, and reporting and promotion
  • Collaborate with the internal team and agency partners to influence, shape, and promote public relations narratives that educate and resonate with the general public and key company stakeholders
  • Disseminate narratives across channels, audiences, and regions to build and sustain awareness for Waters’ innovation and industry excellence
  • Initiate relationships across the company to source stories, value propositions, and proof points that reinforce core external messages
  • Approach communications strategies and campaigns with a data-driven lens
  • Benchmark success with KPIs aligned to business objectives
  • Leverage data to demonstrate communications impact and optimize current processes and results
Desired Qualifications
  • Public relations agency experience

Waters Corporation provides analytical system solutions, software, and services for scientists across biopharma, clinical research, forensics, life science research, food and beverage, and environmental sectors. Its products include high-performance analytical instruments like the BioAccord System, paired with software and ongoing support to enable precise, reproducible results. The company operates by selling instruments and software and offering maintenance and services to enhance user experience and reliability. Compared to competitors, Waters offers an integrated package of hardware, software, and service across multiple markets, focused on delivering accurate analyses and end-to-end workflow solutions rather than just standalone devices. Its goal is to unlock the potential of science by solving problems that affect human health and well-being.

Company Size

10,001+

Company Stage

IPO

Headquarters

Milford, Connecticut

Founded

1958

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 organic growth 11% constant currency; raised full-year guidance to 6.5-8%.
  • Acquired BD Biosciences unit exceeded revenue by $40M; targeting $55M cost synergies.
  • China pharmaceutical revenue grew 50%+ targeting biotech CDMOs and emerging domestic companies.

What critics are saying

  • Competitors release comparable MALS and blood culture systems within 12-18 months, eroding differentiation.
  • $3.5B debt at 4.3-5.2% creates refinancing cliff 2027-2036 if growth slows.
  • BD acquisition integration risks $55M synergy target; supply chain fragmentation could halve realized savings.

What makes Waters Corporation unique

  • BD BACTEC FXI detects bloodstream infections 3 hours faster with automated blood volume measurement.
  • omniDAWN MALS enables 4x faster large molecule analysis with 10x molar mass improvement.
  • ARES-G3 Rheometer reduces testing times 80% while capturing 25,000 data points per second.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Waters Corporation who can refer or advise you

Benefits

Hybrid Work Options

Company News

PR Newswire
Apr 14th, 2026
Waters launches omniDAWN MALS detector for UHPLC, enabling 4x faster analysis of large molecules

Waters Corporation has launched the omniDAWN Multi-Angle Light Scattering Photometer, the first extended-range MALS detector designed for ultra high performance liquid chromatography workflows. The device features 18 detection angles and delivers chromatographic run times up to four times faster than conventional methods. The photometer extends UPLC-compatible sizing tenfold, from approximately 50 to 500 nanometres in radius, enabling characterisation of complex molecules including protein aggregates, viral vectors and lipid nanoparticles. It achieves a 10-fold improvement in absolute molar mass measurements whilst reducing sample consumption by 30–50% and solvent use by roughly 40%. The device integrates with Waters UPLC systems and is powered by ASTRA software, supporting analysis across drug discovery, development and quality control. The omniDAWN photometer will be available globally in summer 2026.

PR Newswire
Apr 8th, 2026
Waters gains FDA clearance for at-home cervical cancer screening kit with HPV assay

Waters Corporation has received FDA clearance for the Onclarity HPV Self-Collection Kit and approval for the BD Onclarity HPV Assay with extended genotyping for at-home use. The kit enables cervical cancer screening from home, addressing barriers that prevent many individuals from routine testing. Approximately 60% of cervical cancer cases occur in unscreened or under-screened individuals. The BD Onclarity HPV Assay is the only FDA-approved test identifying six individual HPV genotypes and three pooled groups, making it the most comprehensive screening tool available in the US. The kit will be available by prescription in coming months and is covered by private insurance, Medicaid and Medicare. Waters is establishing partnerships for broader nationwide access, with patients able to collect samples at home and mail them to laboratories for processing.

Paul Hastings LLP
Mar 23rd, 2026
Waters Corporation subsidiary raises $3.5B through senior notes offering

Paul Hastings advised underwriters including Barclays Capital, Citigroup Global Markets and J.P. Morgan Securities in a $3.5 billion senior notes offering by Augusta SpinCo Corporation, a Waters Corporation subsidiary. The SEC-registered offering comprises five tranches of senior notes maturing between 2027 and 2036, with interest rates ranging from 4.321% to 5.245%. The notes are guaranteed by Waters and certain subsidiaries. Partner Jeff Ramsay led the Paul Hastings team, which included partners Morgan Bale, Ismael Duran and Daniel Nicholas, along with several associates.

Yahoo Finance
Mar 19th, 2026
Waters Corporation stock down 22.8% year-on-year, underperforming Dow's 11.2% rise

Waters Corporation (WAT), a leading scientific instruments manufacturer, is underperforming the Dow Jones Industrial Average significantly. The stock trades 28.8% below its 52-week high of $414.15 and has declined 22.3% year-to-date, compared to the Dow's 3.8% decline. The Milford, Massachusetts-based company, with a market cap of $28.9 billion, specialises in analytical technologies including liquid chromatography and mass spectrometry for pharmaceutical, life sciences and industrial applications. Despite reporting solid fourth-quarter results with revenue of $932 million, up 7% year-over-year, and adjusted earnings per share rising 10% to $4.53, investor sentiment has soured. Cautious first-quarter guidance and concerns over its acquisition of Becton Dickinson's biosciences unit, which is underperforming expectations, have weighed on the stock.

Yahoo Finance
Mar 17th, 2026
Waters Corporation Q4 results mixed as research tools sector faces 20.9% share price decline

Waters Corporation reported Q4 revenues of $932.4 million, down 45.4% year on year, meeting analysts' expectations. The analytical instruments manufacturer delivered mixed results, with next quarter's revenue guidance exceeding expectations but earnings per share guidance falling short. The research tools and consumables sector reported a satisfactory Q4 overall, with the 10 tracked stocks beating revenue consensus estimates by 1.2%. However, share prices have struggled, declining 20.9% on average since latest earnings results. Founded in 1958, Waters develops analytical instruments, software and consumables for liquid chromatography, mass spectrometry and thermal analysis. CEO Udit Batra highlighted the company achieved high single-digit revenue growth and double-digit adjusted EPS growth in 2025, with momentum expected to continue into 2026.